Athersys executives excited about stem cell, drug programs
Executives of biopharmaceutical company Athersys Inc. seem more confident than ever that their stem cell therapy MultiStem could eventually be used to profoundly help patients recover from heart attack, stroke or leukemia. In a conference call with securities analysts late Thursday afternoon, the executives also disclosed promising research on drug candidates to treat obesity and attention …
[Read the full article here]Related News:
Athersys Presents New Data And Advancements In Stem Cell And Drug Development Programs At Annual R&D Day
Athersys stem cells get orphan drug status for bone marrow disease
UTHealth, Athersys Present Preclinical Data Illustrating Potential Benefits of Stem Cells for Stroke